Evidence map›Paper›PMID 38928926›Full record

ArticleInternational journal of environmental research and public health2024

Molecular Surveillance of Artemisinin-Resistant

Jacqueline de Aguiar-Barros, Fabiana Granja, Rebecca de Abreu-Fernandes, Lucas Tavares de Queiroz, Daniel da Silva E Silva, Arthur Camurça Citó, Natália Ketrin Almeida-de-Oliveira Mocelin, Cláudio Tadeu Daniel-Ribeiro, Maria de Fátima Ferreira-da-Cruz

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Tracking Drug Resistance inInternational journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jacqueline de Aguiar-BarrosMalaria Control Center, Epidemiological Surveillance Department, General Health Surveillance Coordination, SESAU-RR, Roraima 69305-080, Brazil.ORCID 0000-0002-8999-1722
Fabiana GranjaPostgraduate Program in Biodiversity and Biotechnology-BIONORTE Network/Roraima Federal University (UFRR), Roraima 69310-000, Brazil.
Rebecca de Abreu-FernandesLaboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-360, Brazil.
Lucas Tavares de QueirozLaboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-360, Brazil.
Daniel da Silva E SilvaBiodiversity Research Centre, Roraima Federal University (UFRR), Roraima 69304-000, Brazil.
Arthur Camurça CitóResearch Support Center in Roraima (NAPRR) of the National Institute for Amazonian Research (INPA), Roraima 69301-150, Brazil.ORCID 0000-0001-9963-8167
Natália Ketrin Almeida-de-Oliveira MocelinLaboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-360, Brazil.
Cláudio Tadeu Daniel-RibeiroLaboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-360, Brazil.
Maria de Fátima Ferreira-da-CruzLaboratório de Pesquisa em Malária, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-360, Brazil.ORCID 0000-0003-3522-3792

Funding

National Council for Scientific and Technological Development 60/2022
6 · The paper itself

Abstract

Multidrug- and artemisinin-resistant (ART-R)

Indexed as

AntimalarialsArtemisininsDrug ResistanceMalaria, FalciparumMiningPlasmodium falciparumAdolescentAdultBrazilFemaleGenotypeHumansMaleMiddle AgedYoung AdultAntimalarialsartemisininArtemisininsAmazonchemoresistanceGuiana Shieldmalariapfk13

Identifiers

PMID38928926
PMCPMC11203648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.